28 | Analgesics (Analgesic Drugs)IBA
08/2023
-
11/2011 |
23 | Opioid Analgesics (Opioids)IBA
06/2023
-
05/2007 |
23 | Morphine (MS Contin)FDA LinkGeneric
06/2023
-
08/2003 |
6 | Type 2 Angiotensin ReceptorIBA
12/2023
-
05/2013 |
6 | KetamineFDA LinkGeneric
10/2022
-
05/2007 |
6 | Pregabalin (Lyrica)FDA Link
01/2021
-
05/2010 |
5 | Angiotensin IIIBA
12/2023
-
10/2013 |
5 | Gabapentin (Neurontin)FDA LinkGeneric
11/2021
-
05/2013 |
4 | EMA400IBA
12/2023
-
05/2013 |
4 | Amitriptyline (Elavil)FDA LinkGeneric
11/2021
-
05/2013 |
4 | Meloxicam (Mobic)FDA LinkGeneric
11/2021
-
05/2013 |
4 | salicylhydroxamic acid (SHAM)IBA
01/2021
-
01/2016 |
3 | Proteins (Proteins, Gene)FDA Link
08/2023
-
01/2018 |
3 | LigandsIBA
06/2023
-
10/2008 |
3 | Dihydrotachysterol (AT 10)IBA
01/2021
-
10/2020 |
3 | Cisplatin (Platino)FDA LinkGeneric
01/2021
-
12/2014 |
3 | Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2021
-
07/2012 |
3 | 2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA
12/2020
-
01/2018 |
3 | Hydromorphone (Dilaudid)FDA LinkGeneric
10/2020
-
04/2010 |
3 | Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2020
-
06/2015 |
3 | Narcotic Antagonists (Opioid Antagonists)IBA
03/2020
-
05/2013 |
3 | Opioid Receptors (Opioid Receptor)IBA
03/2020
-
03/2011 |
3 | 1,2,5-oxadiazole 2-oxideIBA
01/2019
-
09/2015 |
3 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
-
09/2015 |
3 | WL 19IBA
01/2017
-
05/2013 |
3 | Oxycodone (Oxycontin)FDA LinkGeneric
07/2015
-
12/2007 |
3 | Type 1 Angiotensin ReceptorIBA
04/2014
-
10/2013 |
2 | InflammasomesIBA
08/2023
-
02/2018 |
2 | Castor Oil (Oil, Castor)IBA
06/2023
-
03/2020 |
2 | GTP-Binding Proteins (G-Protein)IBA
06/2023
-
03/2011 |
2 | Charcoal (Charbon)IBA
06/2023
-
03/2020 |
2 | Thioctic Acid (Lipoic Acid)IBA
01/2022
-
06/2015 |
2 | Glycine Plasma Membrane Transport ProteinsIBA
01/2021
-
10/2020 |
2 | Ion Channels (Ion Channel)IBA
10/2020
-
01/2018 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
09/2019
-
01/2018 |
2 | CytokinesIBA
07/2018
-
04/2010 |
2 | Naloxone (Narcan)FDA LinkGeneric
01/2017
-
05/2013 |
2 | Angiotensin II Type 2 Receptor BlockersIBA
02/2016
-
04/2014 |
2 | PD 123319IBA
01/2014
-
05/2013 |
2 | Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2012
-
11/2009 |
2 | Xen2174IBA
11/2009
-
11/2005 |
1 | ProdrugsIBA
01/2022 |
1 | EstersIBA
01/2022 |
1 | EsterasesIBA
01/2022 |
1 | Indomethacin (Indometacin)FDA LinkGeneric
01/2021 |
1 | LipidsIBA
10/2020 |
1 | Glial Fibrillary Acidic ProteinIBA
10/2020 |
1 | Amyloid (Amyloid Fibrils)IBA
10/2020 |
1 | endomorphin 2IBA
03/2020 |
1 | kappa Opioid Receptors (kappa Opioid Receptor)IBA
03/2020 |
1 | Respiratory System Agents (Respiratory Stimulants)IBA
01/2020 |
1 | Central Nervous System Depressants (CNS Depressants)IBA
01/2020 |
1 | Stavudine (Zerit)FDA LinkGeneric
04/2019 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2019 |
1 | Polylactic Acid-Polyglycolic Acid CopolymerIBA
01/2019 |
1 | benzonidazole (benznidazole)IBA
01/2019 |
1 | Antiparasitic Agents (Antiparasitics)IBA
01/2019 |
1 | Buprenorphine (Subutex)FDA LinkGeneric
10/2018 |
1 | D-Penicillamine (2,5)- EnkephalinIBA
10/2018 |
1 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
02/2018 |
1 | NLR ProteinsIBA
02/2018 |
1 | Acid Sensing Ion Channel BlockersIBA
01/2018 |